Gut Microbiota May Not Be Fully Restored in Recovered COVID-19 Patients After 3-Month RecoveryOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study asked whether gut microbiome changes seen during COVID-19 persist into recovery. Researchers compared stool from recovered patients and healthy controls using 16S rRNA gene sequencing of the V3-V4 region on an Illumina MiSeq platform. They measured alpha diversity (Shannon, Chao, Simpson), beta diversity, and the relative abundance of specific taxa. Fecal short-chain fatty acids were also quantified by gas chromatography mass spectrometry. The authors describe this as the first look at gut microbiota in people who had recovered from COVID-19.
Who was studied?
The cohort was small: seven men recovered from COVID-19 and seven healthy male controls, all from Hubei province, China. Patients were aged 25 to 45 years, with documented recovery and discharge records. Stool was collected an average of about 90 days after discharge, ranging from 78 to 106 days. Mean hospital stay had been 19.4 days. People who had taken antibiotics or probiotics within two months, or who had gastrointestinal or severe underlying disease, were excluded. All shared a similar moderate-fat diet.
What were the most important findings?
Recovered patients showed reduced gut microbial richness and diversity. The Chao richness index (p = 0.0298) and Simpson diversity index (p = 0.015) differed significantly, though the Shannon index did not (p = 0.055). Beta diversity separated the two groups by NMDS (p = 0.0250). Recovered patients had fewer anti-inflammatory, short-chain-fatty-acid-producing bacteria and more opportunistic pathogens. Despite fewer producer bacteria, measured levels of the seven fecal short-chain fatty acids did not differ between groups, possibly due to compensation by other producers.
What are the greatest implications of this study?
The results suggest the gut microbiome may not fully recover three months after COVID-19, hinting at a lasting effect of infection. Loss of anti-inflammatory bacteria and enrichment of opportunistic pathogens could raise the risk of chronic gut inflammation. The authors urge caution. The sample was very small, male-only, and cross-sectional, with no pre-infection baseline, so causation cannot be established. They recommend continued monitoring of gut health in recovered patients and further study of microbiome-restoring interventions.